Schedule 13G ownership disclosure

Nexvet Biopharma plc

Security class unavailable · CUSIP: G6503X109

Event date: 2015-12-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.1100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-15-008817
Form type
SC 13G
Filer
Broadfin Capital, LLC
CIK
CIK 1511901
Filed
Dec 28, 2015
Reporting period
Dec 18, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub